Publications by authors named "Michela Ceccolini"

Claim this Profile
R
Radiopsy: a prospective observational study on quantitative multiparametric whole-body magnetic resonance imaging to discriminate between smoldering and multiple myeloma.
Giacomo Feliciani, Emiliano Loi, Elena Amadori, Eleonora Antognoni, Andrea Prochowski Iamurri, Michela Ceccolini

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.
Maria Caterina Pallotti, Romina Rossi, Emanuela Scarpi, Monia Dall'Agata, Marianna Ricci, Michela Ceccolini

Support Care Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Massimo Martino, Filippo Antonio Canale, Caterina Alati, Iolanda Donatella Vincelli, Tiziana Moscato, Michela Ceccolini

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Cristina Papayannidis, Viviana Guadagnuolo, Michela Ceccolini

J Transl Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.
Maria Teresa Petrucci, Elisabetta Calabrese, Anna Levi, Vincenzo Federico, Michela Ceccolini

Tumori· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Patrizia Tosi, Barbara Gamberi, Barbara Castagnari, Anna Lia Molinari, Paolo Savini, Michela Ceccolini

Mediterr J Hematol Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).
Gerardo Musuraca, Pier Paolo Fattori, Michela Ceccolini, Delia Cangini, Maria Benedetta Giannini

Am J Hematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
Patrizia Tosi, Elena Zamagni, Paola Tacchetti, Michela Ceccolini, Giulia Perrone

Biol Blood Marrow Transplant· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
Michele Cavo, Francesco Di Raimondo, Elena Zamagni, Francesca Patriarca, Paola Tacchetti, Michela Ceccolini

J Clin Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
Patrizia Tosi, Carolina Terragna, Nicoletta Testoni, Elena Zamagni, Matteo Renzulli, Michela Ceccolini

Eur J Haematol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Elena Zamagni, Cristina Nanni, Francesca Patriarca, Emanuela Englaro, Paolo Castellucci, Michela Ceccolini

Haematologica· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo, Michela Ceccolini

Blood· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Giulia Perrone, Michela Ceccolini

Ann Hematol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Patrizia Tosi, Elena Zamagni, Claudia Cellini, Raffaele Parente, Delia Cangini, Michela Ceccolini

Eur J Haematol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
Michele Cavo, Carolina Terragna, Matteo Renzulli, Elena Zamagni, Patrizia Tosi, Michela Ceccolini

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
Michele Cavo, Elena Zamagni, Patrizia Tosi, Paola Tacchetti, Claudia Cellini, Michela Ceccolini

Blood· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis